irasia.com


Novogen Limited
Key Attributes in Investing in NRT

INVESTMENT HIGHLIGHTS

  • A world-first technology capable of producing drugs that kill standard cancer cells & cancer stem cells in equal measure

  • Game-changing opportunity to deliver long-term remission of cancer through the removal of the cancer stem cells as the source of cancer

  • Aiming for clinical indications of significant unmet clinical need with the opportunity to achieve Breakthrough Therapeutic status with the FDA

  • Highly experienced executive team in the fields of drug design and manufacture, clinical trial design, and interaction with regulatory bodies

  • Sufficient capital to fund medium-term R&D programs leading up to clinical studies

  • Building a unique and highly valued intellectual property portfolio

    • updated 21st August, 2013

  • Company's Index
    		•
  • irasia.com
    		•
    © Copyright 1996-2019 irasia.com Ltd. All rights reserved.
    DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
    TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
    TERMS OF USE: Please read the Terms of Use governing the use of our website.